Papamarkou Wellner Asset Management Inc. Gilead Sciences, Inc. Transaction History
Papamarkou Wellner Asset Management Inc.
- $145 Billion
- Q4 2024
A detailed history of Papamarkou Wellner Asset Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Papamarkou Wellner Asset Management Inc. holds 16,567 shares of GILD stock, worth $1.72 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
16,567Holding current value
$1.72 Million% of portfolio
1.05%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,224Shares Held
984MCall Options Held
8.53MPut Options Held
8.9M-
Black Rock Inc. New York, NY121MShares$12.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.2 Billion0.25% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.27 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.67 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.56 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...